Company / CapEx per Share
Ligand Pharmaceuticals, Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.02
FY2025
5-year range
$0.02 / $1.07
FY2021-FY2025
Trend
-77.2%
vs FY2024
Sector context
#95 of 192
Health Care
What the data says
At $0.02, Ligand Pharmaceuticals, Inc.'s capex per share ranks #95 of 192 in the Health Care sector. CapEx per Share has declined for 3 consecutive years, from $1.07 in FY2022 to $0.02 in FY2025.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of -38.3%.
Declined from $0.21 to $0.02 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -71.9%
- 5-Year CAGR
- -38.3%
- 10-Year CAGR
- -
Sector benchmark
#95 of 192 in Health CareTop 49% of 192This company $0.02 Sector average $3.54
▼
-99.3% below sector average
Key checks
Key Insights
- Ligand Pharmaceuticals, Inc.'s capex per share has declined for 3 consecutive years.
- In FY2025, capex per share decreased 77.2% year-over-year.
- Ranks #95 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -77.2% |
| FY2024 | $0.10 | -50.1% |
| FY2023 | $0.21 | -80.6% |
| FY2022 | $1.07 | +96.2% |
| FY2021 | $0.54 | +105.6% |
| FY2020 | $0.26 | +115.5% |
| FY2019 | $0.12 | +193.1% |
| FY2018 | $0.04 | -59.3% |
| FY2017 | $0.10 | +11.2% |
| FY2016 | $0.09 | +1852.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026